Cargando…
Bisphosphonate drug holidays: Can we recommend currently?
Bisphosphonates (BP) are the mainstay of treatment for osteoporosis. Subtrochanteric or diaphyseal fractures have been reported with long term use of BP, which raised world-wide debate on two aspects, i.e., for how long the BP is to be given and potential advantages/role of BP drug holidays. BP accu...
Autores principales: | Tandon, Vishal R., Sharma, Sudhaa, Mahajan, Annil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195182/ https://www.ncbi.nlm.nih.gov/pubmed/25316995 http://dx.doi.org/10.4103/0976-7800.141186 |
Ejemplares similares
-
First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
por: Tandon, Vishal R., et al.
Publicado: (2014) -
Calcitonin gene-related peptide and menopause
por: Sharma, Sudhaa, et al.
Publicado: (2010) -
Does Coronavirus Disease 2019 Kill More Elderly Men than Women Due to Different Hormonal Milieu
por: Tandon, Apurva, et al.
Publicado: (2022) -
Menopause and Sleep Disorders
por: Tandon, Vishal R., et al.
Publicado: (2022) -
Obesity: Friend or foe for osteoporosis
por: Sharma, Sudhaa, et al.
Publicado: (2014)